• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Dick Dayton, USA

    Dick Dayton, USA

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Jean

    Jean
    jean

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Jason Goodman, USA

    Jason Goodman, USA

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Frank Taylor, USA

    Frank Taylor, USA

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • David Solomon, UK

    David Solomon, UK

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Ali Var, Turkey

    Ali Var, Turkey

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login